Martin-Chouly, Corinne A E <br/><br/>
Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.  [electronic resource] 

 -  Life sciences  Jul 2004 
 - 823-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0024-3205 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2004.01.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases--antagonists & inhibitors<br/>Azepines--pharmacology<br/>Blotting, Western<br/>Bronchodilator Agents--pharmacology<br/>Carboxylic Acids<br/>Cell Line<br/>Cyclic Nucleotide Phosphodiesterases, Type 4<br/>Cyclohexanecarboxylic Acids<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Fibroblasts--drug effects<br/>Humans<br/>Isoenzymes<br/>Lung--drug effects<br/>Matrix Metalloproteinase 1--biosynthesis<br/>Matrix Metalloproteinase 2--biosynthesis<br/>Metalloproteases--biosynthesis<br/>Niacinamide--analogs & derivatives<br/>Nitriles<br/>Phosphodiesterase Inhibitors--pharmacology<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Rolipram--pharmacology<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Transforming Growth Factor beta--pharmacology<br/>Transforming Growth Factor beta1<br/>Tumor Necrosis Factor-alpha--pharmacology